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Abstract
The objectives of the community-based Early Develop-
mental Stages of Psychopathology (EDSP) Study are
described along with a detailed account of the overall
design, special design features, sample characteristics
and instruments used. The EDSP employed a prospec-
tive-longitudinal design to study substance use and oth-
er mental disorders in a representative population sam-
ple of 3,021 subjects aged 14–24 years (birth cohorts
1970–1981) at ‘baseline’ – the outset of the study. Two
follow-up investigations were conducted after the base-
line investigation covering an overall period of 3–4 years.
Special design features are the linkage with a family sup-
plement (EDSP-FS) as well as neurobiological laboratory
studies of high-risk subjects.
Copyright © 2000 S. Karger AG, Basel
Background of the EDSP
In 1994, the German government launched the ‘Bio-
logical and Psychosocial Factors of Drug Abuse’ program
coordinated by the Ministry of Research and Technology
in order to improve the overall knowledge about sub-
stance use disorders. Within this program five epidemio-
logical projects were funded, linked together in a collabo-
rative network named ANEPSA (Analytical Epidemiolo-
gy of Psychoactive Substance Abuse). Aims of the net-
work are to cooperate in the research on the longitudinal
course of substance use, abuse and dependence and in the
analyses of factors related to the onset and change of sub-
stance use patterns. Methods, design and first findings of
the ANEPSA projects have been published in several
journals and books [1–14]. As one of the epidemiological
core projects, the Early Developmental Stages of Psycho-
pathology (EDSP) Study was carried out at the Max
Planck Institute of Psychiatry in Munich, Unit for Clini-
cal Psychology and Epidemiology. The EDSP employed a
prospective-longitudinal design to study pathways into
substance use, abuse and dependence in a representative
population sample of 3,021 subjects initially aged 14–24
years, including a baseline and two follow-up assessments
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Fig. 1. EDSP design.
and an independent parent investigation. In a special
issue of European Addiction Research and several further
publications, the objectives, basic design, description of
the baseline investigation and selected baseline findings
have already been published [15–22, see also ref. 23–25].
Further publications that included first longitudinal find-
ings referring to baseline and first follow-up have been
presented [26–29]. Meanwhile the third and final wave of
the prospective-longitudinal EDSP has been completed
successfully and with this paper we will take the opportu-
nity to provide an overview over the whole EDSP study
and its methodology including all three assessment waves
as well as the independent parent study.
Study Objectives
As the objectives of the EDSP have been presented
already in detail [16], only the general goals are briefly
highlighted here. The primary goal of the study is to pro-
vide prevalence and incidence estimates of substance use,
abuse and dependence among adolescents and young
adults. Secondly, the EDSP aims to study the natural
course of early stages of substance use and substance use
disorders (e.g. initiation of use, progression to abuse) over
a period of several years and to identify risk factors that
are associated with changes from one stage to another.
Further main goals of the EDSP include the examination
of comorbidity of substance use disorders with each other,
as well as with other mental disorders, and the investiga-
tion of familial vulnerability factors and mechanisms that
may be involved in the onset and course of substance use
disorders.
Design
The overall design of the EDSP is a prospective-longi-
tudinal design based on a representative community sam-
ple of adolescents and young adults living in the Munich
area, aged 14–24 years at baseline. The age range for the
targeted population was chosen to address especially the
early developmental stages of substance use, abuse and
dependence and other mental disorders. The EDSP con-
sists of a baseline investigation (T0), two follow-up inves-
tigations (T1, T2) and an independent parent survey.
Because of the focus on early developmental stages of psy-
chopathology and substance use, only the younger cohort
of adolescents, aged 14–17 years at baseline, was exam-
ined in the first follow-up investigation. In the final fol-
low-up investigation, the entire baseline sample was as-
sessed again.
Total
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A key design feature of the EDSP is a special family
supplement (EDSP-FS) to investigate the familial contri-
butions to the development of substance use and other
mental disorders. In order to identify familial vulnerabili-
ty factors and mechanisms involved in the onset and
course of mental disorders, baseline and follow-up inves-
tigations included a family history module to gather infor-
mation about substance use and mental disorders in
respondents’ parents and siblings. Separate face-to-face
interviews were conducted with the parents of the respon-
dents of the first follow-up in order to gather more com-
prehensive direct information than at baseline about
family genetic variables. In addition, information for
childhood development and childhood disorders was col-
lected as part of these parent interviews.
Figure 1 summarizes the overall design of the EDSP.
On the left side, the two columns represent family genetic
and familial socialization factors as well as early biological
and psychosocial characteristics assessed in the direct par-
ent interviews. On the right side, the three waves of inter-
views with our sample aged 14–24 at the outset of the
study are shown, providing information about their use of
all legal and illegal psychotropic substances on the level of
use, pattern of use, symptoms and diagnosis. The refer-
ence periods of assesssment include lifetime and 12-
month time frames; furthermore due to variable time dis-
tances of interviews between waves 1 and 2 as well as 2
and 3 special attempts were made to collect information
on the time intervals beyond 12 months.
Sample
Sampling of the Respondents and Baseline
Investigation
The EDSP sample was drawn randomly from the 1994
government population registers of residents in metropol-
itan Munich and its surroundings with an expected age
range for the sampled subjects between 14 and 24 years
(birth cohorts 1970–1981) at the time of the baseline
interview in 1995. As the study is designed with special
interest in early stages of substance use disorders, 14- to
15-year-olds were sampled at twice the probability of per-
sons 16–21 years of age, and 22- to 24-year-olds were sam-
pled at half this probability. A total of 3,021 interviews
were completed at baseline, resulting in a response rate of
71%. Detailed descriptions of the sampling procedures of
the baseline investigation and reasons for nonresponse
have already been presented elsewhere [8, 16].
First and Second Follow-Ups
Two follow-up investigations were completed after the
baseline investigation, covering an overall period of 3–4
years. Due to the large number of respondents, it was
technically not feasible to keep a constant time interval
between the different waves. The first follow-up was con-
ducted in 1996/1997, an average of 19.7 months after
baseline (range: 14–25 months). This wave included only
the respondents who were 14–17 years old at baseline (n =
1,395; birth cohorts 1977–1981). Of the baseline 14- to
17-year-old respondents, 1,228 participated in the first
follow-up investigation, resulting in a response rate of
88%. The most frequent reasons for nonresponse were
refusal to participate (6.4%), lack of time (1.5%) and fail-
ure to contact the individual (1.5%).
The second follow-up investigation included all base-
line respondents and was conducted in 1998/1999, an
average of 42 months after the baseline investigation
(range: 34–50 months). Of the 3,021 baseline respon-
dents, 2,548 participated again in the second follow-up
investigation, resulting in a response rate of 84%. Again,
the most frequent reasons for nonresponse were refusal to
participate (9.2%), failure to contact the individual
(2.7%) and lack of time (1.5%). Table 1 shows the re-
sponse rates in the second follow-up by sex and age
groups.
Table 1. Response rates in the second follow-up investigation (by sex
and age groups)
Baseline sample (T0)
n %
Response rates in
second follow-up (T2)
n % T01
3,021 100 2,548 84.3
Men
Total 1,533 50.7 1,297 84.6
14–15 years 470 15.6 400 85.1
16–17 years 244 8.1 203 83.2
18–19 years 241 8.0 202 83.8
20–21 years 243 8.0 206 84.8
22–24 years 335 11.1 286 85.4
Women
Total 1,488 49.3 1,251 84.1
14–15 years 433 14.3 362 83.6
16–17 years 248 8.2 204 82.3
18–19 years 219 7.2 190 86.8
20–21 years 255 8.4 214 83.9
22–24 years 333 11.0 281 84.4
1 Percentage of baseline sample (T0; n = 3,021)
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Sociodemographic Characteristics
Table 2 shows the distribution of some sociodemo-
graphic variables in the sample at baseline and second fol-
low-up for the total group and by gender. At baseline,
36.2% of the respondents were in secondary school. Most
(24.0%) attended ‘Gymnasium’ (secondary education be-
tween ages of 10 and 19 that prepares students for
entrance to university), 9.3% attended a more basic or
intermediate level of school (‘Hauptschule’, a mandatory
basic school, or ‘Realschule’, an intermediate type of
advanced school between Hauptschule and Gymnasium).
26.4% of the respondents attended university, 10.5%
were in job training and 19.7% were employed. The
majority of respondents (62.4%) were living with their
parents, and only a few (3.4%) were married. The vast
majority of respondents were classified as (upper) middle
class (87.4%), which is consistent with the demographics
of the Munich population. Only 7.6% reported lower
social class status.
At the time of the second follow-up investigation, a
considerably lower proportion of respondents (12.8%)
was still attending a school other than university, while
more respondents (36.2%) were employed. A lower pro-
portion of respondents (40.2%) still lived with their par-
ents, while more subjects lived with a partner (22.7%) or
in other living arrangements (11.4%). No remarkable
changes were found with regard to the respondents’
reported social class and financial situations. The propor-
tion of married respondents doubled from baseline to sec-
ond follow-up (7.8%).
Separate Parent Investigation
Given the resources available for the EDSP, we had to
limit the parent investigation to direct parent interviews
with only one parent of a subsample of respondents.
Therefore, only parents of respondents aged 14–17 years
at baseline who participated in the first follow-up investi-
gation were included. Because we intended to gather
detailed information not only about the occurrence of
psychopathology in the respondents’ families, but also
about birth complications, psychological and somatic
symptoms in the respondents’ infancy and early child-
hood, we focused primarily on the respondents’ mothers.
Fathers were interviewed only if the mother was dead or
not locatable. In 1997, the parents of 1,053 adolescents
were interviewed directly, resulting in a response rate of
86%. For 1,026 adolescents the mother was interviewed,
and for 27 adolescents the father was interviewed. The
respondent sample of 14- to 17-year-olds included four
pairs of siblings; in these cases only one parent interview
was conducted for each sibling pair, although separate
information was gathered for each of the respondents.
Nonresponse in parents was predominantly due to refusal
to participate (12.9%), failure to contact parents (0.7%)
and lack of time (0.5%).
Figure 2 provides an overview of the number of re-
spondents and response rates for the three waves of
assessment (T0, T1, T2) as well as for the parent investiga-
tion.
Instruments
Assessment of Adolescents and Young Adults
In all three waves of investigation, symptoms and diag-
nostic assessments were based on the computer-assisted
version of the Munich-Composite International Diagnos-
tic Interview (M-CIDI) [30]. The M-CIDI is an updated
version of the World Health Organization’s CIDI version
1.2 [31] incorporating questions assessing DSM-IV [32]
and ICD-10 [33] criteria. The M-CIDI allows for the stan-
dardized assessment of symptoms, syndromes and diag-
noses of a wide range of DSM-IV substance use and men-
tal disorders (and additional various subtypes of main dis-
orders) along with information about onset, duration,
clinical and psychosocial severity. (The complete M-CIDI
is available on request.) Detailed descriptions of the M-
CIDI along with its assessment of substance use, abuse
and dependence have already been described in detail
elsewhere [16, 17]. In the baseline investigation, the life-
time version of the M-CIDI was used to assess lifetime
and 12-month information. For the two follow-up investi-
gations, the M-CIDI was modified to cover the 12-month
period prior to the follow-up interview as well as the
remaining interval between the investigations (12-months
interval version). To assess the course of disorders re-
ported in prior investigations, a special lifetime chart was
used in the second follow-up in which the respondent was
asked to evaluate the duration and severity of every psy-
chopathological problem reaching at least a subthreshold
diagnostic level at baseline or either follow-up, covering
the whole lifespan. Diagnostic assignment is based on the
M-CIDI diagnostic package ‘DSM-IV diagnostic algo-
rithms’ [30]. Due to the standardization and computeriza-
tion of the interview and assignment of diagnoses the
assessment can be regarded as highly objective.
In each wave, the respondents were given a special M-
CIDI response booklet with several symptom lists and
visual aids to improve lifetime recall, facilitate memory
search and help the respondent to answer onset and recen-
Employment
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Table 2. Distribution of sociodemographic variables in the baseline and second follow-up sample (aged 14–24 at baseline)
Baseline sample
total
(n = 3,021, nw = 3,021)
n %w 95% CI
men
(n = 1,533, nw = 1,493)
n %w 95% CI
women
(n = 1,488, nw = 1,528)
n %w 95% CI
School 1,565 36.2 34.4–37.9 804 36.8 34.4–39.4 761 35.5 33.0–38.0
University 555 26.4 24.5–28.4 282 27.3 24.7–30.1 273 25.6 23.0–28.3
Job training 306 10.5 9.4–11.7 165 11.2 9.6–13.0 141 9.9 8.4–11.6
Employed 415 19.7 18.0–21.5 171 16.4 14.2–18.8 244 22.9 20.4–25.7
Unemployed 28 1.1 0.8–1.7 18 1.4 0.9–2.3 10 0.9 0.5–1.6
Other 152 6.1 5.2–7.2 93 6.9 5.6–8.5 59 5.3 4.1–6.9
School type
Hauptschule 166 3.1 2.6–3.6 106 4.0 3.3–4.9 60 2.2 1.7–2.9
Realschule 305 6.2 5.5–7.0 148 6.1 5.1–7.2 157 6.4 5.4–7.5
Gymnasium 993 24.0 22.5–25.5 497 23.6 21.5–25.7 496 24.4 22.3–26.6
Fachoberschule 41 1.4 1.0–1.9 23 1.6 1.0–2.4 18 1.1 0.7–1.8
Other 60 1.5 1.1–2.0 30 1.6 1.1–2.4 30 1.4 0.9–2.0
No school 1,456 63.9 62.1–65.6 729 63.2 60.6–65.6 727 64.5 62.0–67.0
Living arrangements
With parents 2,245 62.4 60.3–64.5 1,208 67.3 64.4–70.2 1,037 57.6 54.7–60.5
Alone 470 22.7 20.9–24.6 219 22.2 19.6–24.9 251 23.2 20.7–25.9
With partner 229 11.6 10.2–13.1 78 8.2 6.6–10.2 151 14.9 12.7–17.3
Other 77 3.4 2.6–4.3 28 2.3 1.6–3.4 49 4.4 3.2–5.9
Social class
Lowest 24 1.0 0.6–1.5 17 1.4 0.8–2.3 7 0.6 0.3–1.3
Lower middle 183 6.6 5.7–7.7 104 7.3 5.9–8.9 79 6.0 4.7–7.6
Middle 1,804 59.1 57.1–61.0 877 57.3 54.5–60.1 927 60.8 57.9–63.5
Upper middle 854 28.3 26.5–30.1 451 28.7 26.2–31.3 403 27.9 25.4–30.5
Upper 96 3.2 2.5–4.0 52 3.3 2.4–4.5 44 3.0 2.2–4.2
None 60 1.9 1.4–2.5 32 2.0 1.4–3.0 28 1.7 1.1–2.6
Financial situation
Very bad, bad 213 8.2 7.2–9.5 117 9.4 7.8–11.3 96 7.1 5.7–8.7
Neither good nor bad 830 28.0 26.3–29.9 428 27.9 25.5–30.5 402 28.2 25.7–30.8
Good 1,633 52.8 50.7–54.8 814 52.0 49.1–54.8 819 53.5 50.7–56.4
Very good 345 11.0 9.8–12.3 174 10.7 9.1–12.5 171 11.3 9.6–13.2
Marital status
Married 66 3.4 2.7–4.4 17 1.8 1.1–3.0 49 4.9 3.7–6.6
Separated 5 0.3 0.1–0.7 1 0.1 0.0–1.0 4 0.4 0.2–1.1
Divorced 1 0.1 0.0–0.4 0 0.0 1 0.1 0.0–0.8
Widowed
Never married 2,949 96.3 95.3–97.1 1,515 98.0 96.8–98.8 1,434 94.6 92.9–95.9
n = Unweighted number of respondents; nw = weighted number; %w = weighted percentage;
95% CI = 95% confidence interval of the weighted percentage.
cy questions of reported symptoms. Furthermore, the
response booklet contained several scales and question-
naires to assess selected psychological constructs. In addi-
tion to the information concerning the respondents’ own
behaviors and history, the baseline and second follow-up
interviews included a separate family history module of
the M-CIDI to evaluate substance use, substance use dis-
order and history of psychopathology in parents and other
family members of the respondents (siblings and grand-
parents).
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Second follow-up
total
(n = 2,548, nw = 2,547)
n %w 95% CI
men
(n = 1,297, nw = 1,262)
n %w 95% CI
women
(n = 1,262, nw = 1,284)
n %w 95% CI
12.8 11.7–14.0 291 13.0 11.5–14.7 269 12.6 11.1–14.3
559 25.6 23.7–27.5 291 26.1 23.5–29.0 268 25.0 22.3–27.8
386 10.9 9.8–12.2 205 11.5 9.9–13.3 181 10.4 8.9–12.1
714 36.2 34.1–38.5 344 35.2 32.2–38.3 370 37.3 34.2–40.4
26 1.1 0.7–1.7 9 0.7 0.3–1.4 17 1.6 0.9–2.7
303 13.3 11.9–14.9 157 13.5 11.5–15.8 146 13.2 11.2–15.5
2 0.0 0.0–0.2 1 0.0 0.0–0.3 1 0.1 0.0–0.3
32 0.6 0.4–0.9 21 0.8 0.5–1.2 11 0.4 0.2–0.8
426 9.5 8.6–10.5 218 9.4 8.2–10.8 208 9.6 8.3–11.1
75 1.9 1.5–2.4 39 2.1 1.5–2.9 36 1.7 1.2–2.4
25 0.8 0.5–1.2 12 0.8 0.4–1.4 13 0.8 0.5–1.5
1,988 87.2 86.0–88.3 1,006 87.0 85.3–88.5 982 87.4 85.7–88.9
1,368 40.2 38.2–42.3 767 45.3 42.4–48.3 601 35.2 32.5–38.0
509 25.7 23.7–27.7 274 28.2 25.4–31.2 235 23.2 20.5–26.1
421 22.7 20.8–24.8 147 16.6 14.2–19.4 274 28.7 25.8–31.8
250 11.4 10.1–12.9 109 9.8 8.1–11.9 141 12.9 10.9–15.3
14 0.5 0.3–0.9 8 0.6 0.3–1.2 6 0.5 0.2–1.1
230 9.8 8.6–11.2 127 10.5 8.8–12.5 103 9.1 7.4–11.1
1,524 60.2 58.1–62.3 741 58.6 55.6–61.6 783 61.8 58.8–64.8
682 25.6 23.7–27.5 371 26.4 23.8–29.1 311 24.8 22.2–27.6
53 2.0 1.5–2.6 34 2.5 1.7–3.6 19 1.5 0.9–2.4
45 2.0 1.4–2.7 16 1.5 0.9–2.5 29 2.4 1.6–3.6
151 6.8 5.8–8.0 73 6.5 5.1–8.2 78 7.2 5.7–9.0
738 28.9 27.0–31.0 393 30.2 27.4–33.0 345 27.7 25.0–30.6
1,367 53.7 51.6–55.9 666 51.1 48.0–54.2 701 56.4 53.2–59.4
269 10.5 9.2–12.0 161 12.3 10.4–14.5 108 8.8 7.1–10.8
133 7.8 6.5–9.2 42 5.2 3.8–7.1 91 10.3 8.4–12.7
3 0.2 0.1–0.7 0 0.0 3 0.4 0.1–1.4
12 0.8 0.4–1.4 4 0.5 0.2–1.3 8 1.0 0.5–2.1
1 0.0 0.0–0.1 0 0.0 1 0.0 0.0–0.3
2,399 91.2 89.7–92.6 1,251 94.3 92.4–95.8 1,148 88.2 85.7–90.3
Reliability and Validity of the M-CIDI
Reliability and procedural validity of the M-CIDI were
tested in several studies. Briefly, test-retest reliability (re-
test after an average period of 39 days, n = 60 of the com-
munity sample) was fair to good for substance use disor-
ders, ranging from Î = 0.64 (Yules Y = 0.80) for drug use
disorders to Î = 0.78 (Yules Y = 0.82) for alcohol use dis-
orders [34]. Procedural clinical validity was examined in
68 patients comparing M-CIDI diagnoses with clinicians’
best-estimate diagnoses and taking into account all avail-
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Fig. 2. Overview over number of respondents and response rates of the different EDSP waves.
able information (medical records, diagnostic interview,
diagnostic checklist) at the end of the patients’ treatment
[35]. For substance use disorders the agreement was very
good, with Î = 0.86 for any substance use disorder and Î =
0.83 for nicotine dependence. Measures of sensitivity and
specificity were excellent for substance use disorders. De-
tailed analyses covering validity and reliability of single
diagnostic criteria and age, frequency and quantity infor-
mation are provided elsewhere [17, 34–36].
Assessment of Other Psychological Constructs
As noted above, the M-CIDI was supplemented by a
separate response booklet that included several scales and
questionnaires for assessing relevant psychological con-
structs. Descriptions of some of these constructs as well as
the assessment instruments have already been published
partially in previous papers [10, 16, 27]. Table 3 provides
an overview over the constructs and instruments used
together with their time of assessment.
The EDSP Family Supplement (EDSP-FS)
The main goals of the EDSP-FS are (1) to explore how
familial psychopathology is linked to the onset, course
and comorbidity of mental disorders in children, (2) to
elucidate the interplay of familial psychopathology and
familial socialization factors, and (3) to investigate famil-
ial aggregation of mental disorders on the basis of a repre-
sentative community sample. Using detailed diagnostic
information about the presence of psychopathology in the
grandparents, parents and siblings of all respondents, the
specificity and comorbidity of the familial aggregation of
mental disorders is being studied as well as the impact of
Substance-related variables
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Table 3. Measures used in the EDSP study to assess major constructs
Construct Assessment instrument Time of assessment
T0 T1 T2
Use of psychotropic substances (age of onset, quantity, frequency) Specific substance sections of the M-CIDI x x x
DSM-IV substance abuse and dependence Specific substance sections of the M-CIDI x x x
Substance use situations, use in peer group, availability Specific questions within the substance sections of the M-CIDI x
Motivation for smoking Fragebogen zur Erfassung des Gesundheitsverhaltens [37]1 x x x
Motivation for drinking alcohol Fragebogen zur Erfassung des Gesundheitsverhaltens [37]1 x x x
Alcohol outcome expectancies Effects of Drinking Alcohol Scale [38] x x x
Motivation for taking drugs Fragebogen zur Erfassung des Gesundheitsverhaltens [37]1 x x
Other intrapersonal variables
Anxiety disorder Anxiety disorder section of the M-CIDI x x x
Affective disorder Affective disorder section of the M-CIDI x x x
Any other mental disorder Somatoform disorder, eating disorder and posttraumatic stress
disorder section of the M-CIDI x x x
Impairments and disability Specific M-CIDI module x x x
Health behavior Fragebogen zur Erfassung des Gesundheitsverhaltens [37]1 x
Psychiatric symptom distress Symptom Checklist 90 Revised [39] x x x
Live events Münchner Ereignis-Liste [40] x x x
Self-esteem Vergleich von Kompetenzen Skala [41] x
Self-esteem/competence Aussagen-Liste zum Selbstwertgefühl für Kinder und Jugendliche [42] x
Self-control and coping skills Skala zur Erfassung von Problemlösekompetenzen [43] x
Behavioral inhibition Retrospective self-report of inhibited behavior during childhood [44] x
Daily stressors/hassles Daily Hassles Scale [45] x x x
Recalled parental rearing behavior Fragebogen zum erinnerten Erziehungsverhalten [46] x x
Mood Stimmungsskala [47] x
Affect lability Affect lability scale [48] x x
Resilience Resilience scale [49] x
Volition Selbststeuerungsinventar [50] x
Disorder-specific variables
Premenstrual symptoms Premenstrual Symptom Scale [51] x x x
Depression (attribution) Reason for Depression Questionnaire [52] x
Suicide attempt Fragebogen zu Selbstmordversuchen [53] x
Panic (health belief model) Erleben des ersten Angstanfalls [54] x x
Antisocial behavior Antisocial personality disorder scale and questions of the SCID-II [55]1 x
1 Modified version.
different manifestations of familial loading of psychopa-
thology on the onset and course of mental disorders.
In general, there are two basic methodological ap-
proaches to assess psychopathology in family members:
(1) the family study method, which involves the direct
interview of each family member concerning his or her
own symptoms, and (2) the family history method, which
involves obtaining diagnostic information from the re-
spondent or a relative as an informant about all other
family members. Advantages and limitations of each
approach have been discussed [56–59]. Taking into ac-
count what could realistically be assessed in a large com-
munity sample – (a) the collection of family history infor-
mation about all first-degree relatives of the respondents,
using the respondent as informant, and (b) the additional
assessment of direct diagnostic information about paren-
tal psychopathology from respondents’ parents as a sec-
ond source was chosen as strategy to gather the best infor-
mation possible about familial psychopathology.
(a) In the EDSP, family history information about psy-
chopathology in the respondents’ relatives was assessed
by specific M-CIDI family history modules that were
administered at baseline (T0) and second follow-up (T2)
to all EDSP respondents. Family history items were
designed taking the Family History Research Diagnostic
Criteria [60] as a basic model. In the baseline investiga-
tion, the stem questions from the full M-CIDI were used
to obtain fmily history information for the mothers and
fathers of respondents, about the same DSM-IV axis I dis-
orders that are in the M-CIDI. Additional questions were
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asked to determine if any of the respondents’ first-degree
relatives had ever sought professional help because of a
mental disorder or substance abuse problem. For the sec-
ond follow-up survey, an extended version of the M-CIDI
family history module was developed that contained fully
structured sections covering DSM-IV criteria for nicotine
dependence, major depression, manic episodes, anxiety
disorders (panic disorder, agoraphobia, social phobia,
specific phobia, generalized anxiety disorder), alcohol and
drug abuse and dependence, and bulimic attacks. Respon-
dents provided information about their parents and sib-
lings. For siblings younger than 10 years old, only separa-
tion anxiety was assessed.
(b) Although the most accurate strategy for the addi-
tional assessment of familial psychopathology in respon-
dents’ parents would have been to conduct direct inter-
views with all mothers and all fathers, resources limited us
to directly interviewing only the parents of the subsample
of the 14- to 17-year-olds, as well as to only one parent
(predominantly the mother) of each respondent. The par-
ents of 1,053 adolescents (see above) were independently
assessed with the M-CIDI, thus providing full diagnostic
information (M-CIDI/DSM-IV criteria) for the inter-
viewed parents [61]. Similar to the family history module
used in the baseline investigation, the parent M-CIDI
included a family history module that collected family
history data about the same DSM-IV axis I disorders that
are in the M-CIDI disorders in the noninterviewed par-
ents as well as in the respondents’ grandparents. Informa-
tion about alcohol use disorders was also assessed for par-
ents’ brothers and sisters [62].
Assessment of Information about Familial
Socialization and Childhood Variables
Information about familial socialization variables,
such as parenting style or family functioning characteris-
tics, that might be important in the development of sub-
stance use and other mental disorders were assessed from
the respondents themselves as well as from the inter-
viewed parents. Furthermore, information about respon-
dents’ childhood developmental characteristics (e.g. birth
complications, childhood disorders) was collected from
the interviewed parents. Table 4 provides an overview of
the main familial psychopathology, family environment,
socialization and early developmental constructs assessed
in the different EDSP assessment stages.
Field Work
Interviewer and Interviewer Training
In all assessment stages interviews were conducted by a
total of 57 clinical interviewers, mostly graduated psy-
chologists; 25 professional health research interviewers
recruited from a survey company (Infratest Gesundheits-
forschung) were additionally involved in the baseline
investigation. Parent interviews were predominantly con-
ducted by female interviewers in the age range of the tar-
geted mothers. Interviewers of the parent study were
blind to the diagnoses of the respondents.
All interviewers participated in 1 week of training for
both the computerized and the paper-pencil version of the
M-CIDI. This was followed by at least 10 practice inter-
views that were closely monitored and supervised by the
staff of the study. Immediately prior to the beginning of
the field work for the baseline investigation, there was a
1-day booster session to stress important points and tech-
niques and increase the motivation of the interviewers.
Before each of the follow-ups and the parent study, an
intensive M-CIDI training session took place, which em-
phasized special features and changes in the version of the
interview used in that stage of the study. Many interview-
ers conducted interviews in several waves of the EDSP so
that they can be called to be very experienced in carrying
out M-CIDI interviews (for further details of recruitment
of interviewers, see Wittchen et al. [16]). During field
work all interviewers were regularly supervised by special-
ly trained M-CIDI clinical editors from the Max Planck
Institute. All interviews were checked according to a stan-
dard procedure for both formal consistency as well as
appropriate recording and coding. During weekly editing
sessions, detailed feedback was given to every interviewer
to avoid errors in later interviews and to clarify remaining
questions. The editors also gave instructions for reassess-
ment of missing values or questionnaires.
For the success of the study, primarily in terms of
response rates, it was necessary to promote and maintain
high motivation of the respondents throughout the entire
study period. Before the baseline investigation, all sam-
pled subjects received a letter with information about the
aims, objectives and methodology (interview) of the
study. The letter explained how data would be protected
and that participation was voluntary. Respondents were
told that they would be contacted by telephone to sched-
ule an interview. The respondents were free to choose the
time and place for the interview, and most interviews
took place in the respondent’s home. Two telephone cards
worth DM 12 (USD 6) were given to respondents as an
Familial psychopathology
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Table 4. Family and early childhood variables assessed in the different waves and parent investigation of the EDSP
Construct Assessment stage1
T0 T1 T2 P
History of mental disorders in parents x – x x
History of mental disorders in siblings – – x –
History of mental disorders in grandparents – – – x
Familial stress2
Death of parents x – – x
Divorce of parents x – – x
Familial stress events during the last 5 years x – – –
Sociodemographics of parents – – – x
Early parenthood of respondents’ parents – – – x
Financial situation of the family (in respondents’, first 5 years of life) – – – x
Social situation of mother (in respondents’, first 5 years of life) – – – x
Mental health of mother (in respondents’, first 5 years of life) – – – x
Physical health of mother (in respondents’, first 5 years of life) – – – x
Familial relationship3
Actual relationship to mother and father x – – –
Family functioning – – – x
Parental educational style – – – x
Familial relationships – – – x
Recalled parenting rearing behavior – x x –
Familial substance environment4
Parental attitude towards legal, illegal drugs x – – –
Availability of alcohol, medications at home x – – –
Childhood development characteristics5
Natal complications – – – x
Somatic symptoms, sensory symptoms, physical disabilities – – – x
ADHD – – – x
Conduct disorder – – – x
Oppositional defiant disorder – – – x
Marked affect lability – – – x
Help-seeking behavior in infancy and childhood – – – x
1 T0 = Baseline investigation, informants are baseline respondents (total n = 3,021); T1 = first follow-up investiga-
tion, informants are respondents of first follow-up (total n = 1,228); T2 = second follow-up investigation, informants
are respondents of second follow-up (total n = 2,548); P = parent investigation, Informants are interviewed parents of
respondents (total n = 1053).
2 Standard questions about family stress assessed in the sociodemographic M-CIDI module (T0) and the family
environment/childhood development M-CIDI module of the parent survey.
3 Assessment of familial relationship: actual relationship to mother and father: standard question in the sociodemo-
graphic M-CIDI module (T0); family functioning: Family Assessment Device [63]; parental educational style: Skala
elterlicher Erziehungsmassnahmen [64]; familial relationships: Subjektives Familienbild [65]; Recalled parenting
rearing behavior: Fragebogen zum erinnerten elterlichen Erziehungsverhalten [46].
4 The familial substance environment was assessed in the family history module of the M-CIDI.
5 The childhood development characteristics were assessed from directly interviewed parents (total n = 1,053) in the
family environment/childhood development M-CIDI-module of the M-CIDI used in the parent survey; natal compli-
cations, somatic and sensory symptoms and physical disabilities were assessed by a standardized checklist [10]; atten-
tion-deficit/hyperactivity disorder (ADHD), conduct disorder and oppositional defiant disorder were assessed with
questions covering the criteria defined by the DSM-IV.
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incentive for participation. Informed consent of the par-
ents was obtained for respondents under the age of 18
years. To increase participation, several special efforts
were made: (a) addresses of subjects who were contacted
several times without success were given to another inter-
viewer of the opposite sex, (b) at least 10 attempts to con-
tact each subject were made at different times of the day
and week, including evenings and weekends, (c) inter-
viewers who were especially successful in contacting were
trained to recontact subjects who were difficult to reach,
(d) motivation letters were sent to unreachable subjects
with a telephone card enclosed to call back, and (e) up to
DM 50 (USD 25) was offered to motivate the most indeci-
sive subjects to participate.
The field work of the follow-ups entailed a lot of effort
to relocate all of the respondents. Due to the high mobility
of the examined age group (e.g. moving out of the parents’
home, moving to another town to go to university) and
changes of last names after marriage, diligent searches
were necessary to locate these subjects. All but 1.7% of
subjects could finally be located and recontacted. Subjects
who had moved to foreign countries during the follow-up
period were contacted by telephone and asked to partici-
pate in a telephone interview. Telephone interviews con-
sisted of the M-CIDI conducted in the same way as the
face-to-face interview. Subjects who had moved to anoth-
er city in Germany were visited at their new residence for
a face-to-face interview. If it was not possible to conduct a
face-to-face interview, telephone interviews analogous to
those with subjects living in foreign countries were con-
ducted.
Statistical Aspects
Measures
As described above (fig. 1), the EDSP study design
entailed a baseline assessment (T0) and two follow-up
interviews (T1, T2) that were held at approximately 18-
month intervals. Following this longitudinal panel design,
retrospective data (lifetime symptomatology assessed at
baseline) is combined with prospective data (follow-up
incidence). Interim symptomatology between the baseline
and the two follow-up investigations was assessed at each
follow-up by using the 12-month interval version of the
M-CIDI. With information from the three assessments
the following measures can be derived: lifetime and cross-
sectional prevalence rates and incidence rates. For cross-
sectional prevalence and incidence, several time frames
can be considered (e.g. 12-month or interim). For defini-
tions and more detailed descriptions of these and other
commonly used epidemiological terms and measures see
Wittchen et al. [16].
Sample and Weighting
As the EDSP is designed with special interest in early
stages of psychopathology, 14- to 15-year-olds were sam-
pled at twice the probability of 16- to 21-year-olds, and
22- to 24-year-olds were sampled at half this probability
[8, 16]. This sampling strategy allows particularly precise
estimations of measures used for comparative analyses
for the age group of primary interest, i.e. 14- to 15-year-
olds. Due to the different sampling probabilities, relative
weights inversely proportional to the sampling fraction
are used in the estimation of measures which are general-
ized to the sampling frame. In addition, these weights also
account for nonresponse according to age, gender and geo-
graphic distribution (urban vs. rural) of the respondents
to that of the registered sampling frame. For data from the
first follow-up investigation which included only the 14-
to 17-year-olds, a special weight was computed for the
subpopulation of the younger cohort, also adjusting for
dropout from baseline to first follow-up according to age,
gender, geographic distribution and nonresponse. For
data from the second follow-up, the same weights as those
of the baseline investigation are used, because there was
no selective attrition due to age, gender or geographic dis-
tribution for which we had to adjust.
Comment
Unique features of the EDSP are (1) a combined longi-
tudinal characterization of psychopathology and sub-
stance use behaviors and disorders, and (2) a prospective-
longitudinal assessment of various risk and protective fac-
tors that are involved in the development of substance use
and other mental disorders (3) in a representative sample
of adolescents and (4) young adults along with a character-
ization of family factors. Prospective-longitudinal designs
in representative population samples, as used in our
study, are essential for an unbiased characterization of the
psychopathological status of the population and the iden-
tification of putative risk factor constellations, since clini-
cal samples are usually influenced by selection bias and in
general allow only for retrospective approaches. There-
fore, the different design features of the EDSP and its
family supplement provide the unique opportunity of not
only describing prevalence and prospectively observed
incidence patterns of substance use and mental disorders
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in the target population on various diagnostic levels
(asymptomatic, symptomatic, subthreshold and full diag-
nostic level), but they also offer an adequate basis for
investigating a variety of familial, cognitive-behavioral
and social risk factors and in particular their status as
causal risk factors. Further, the EDSP allows to study var-
ious public-health-related consequences of substance use
and other mental disorders prospectively and unaffected
by recall bias. Besides these strengths of the design fea-
tures of the EDSP, the quality of the assessed data has to
be outlined: the collected data are based on comprehen-
sive standardized interviews, which were conducted by
trained and highly experienced interviewers. Further-
more, the response rates in the different waves of investi-
gation (ranging from 70.9 to 88.0%) as well as the overall
response rate of 84.3% must be seen as most successful.
Taking these strengths into account, the aims and objec-
tives of the EDSP can be pursued in the frame of a unique
design and excellent data.
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